NNZ-2591 TFA salt is primarily investigated for its potential therapeutic applications in neurological disorders. It has shown promise in preclinical studies for treating conditions such as traumatic brain injury (TBI) and neurodevelopmental disorders like Phelan-McDermid syndrome. The compound is believed to modulate neuroprotective and neuroregenerative pathways, aiding in the repair of neuronal damage and improving cognitive and motor functions. Its application extends to research focused on understanding and mitigating the effects of neurodegeneration and synaptic dysfunction. Ongoing studies aim to explore its efficacy in clinical settings, particularly in addressing unmet medical needs in central nervous system disorders.